141 related articles for article (PubMed ID: 31492291)
1. Transferrin Modified Dioscin Loaded PEGylated Liposomes: Characterization and
Wang Y; Yang Y; Yu Y; Li J; Pan W; Yang X; Zhang Z; Jiang S; Yang X; Wang X
J Nanosci Nanotechnol; 2020 Mar; 20(3):1321-1331. PubMed ID: 31492291
[TBL] [Abstract][Full Text] [Related]
2. Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects.
Zhao X; Yang Y; Su X; Xie Y; Liang Y; Zhou T; Wu Y; Di L
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893242
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and gene expression of transferrin modified gene loaded procationic liposomes].
Zhong ZR; Liu J; Deng Y; Zhang ZR; Song QG; He Q
Yao Xue Xue Bao; 2007 Feb; 42(2):216-20. PubMed ID: 17518055
[TBL] [Abstract][Full Text] [Related]
4. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
5. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
Kong L; Li XT; Ni YN; Xiao HH; Yao YJ; Wang YY; Ju RJ; Li HY; Liu JJ; Fu M; Wu YT; Yang JX; Cheng L
Int J Nanomedicine; 2020; 15():2841-2858. PubMed ID: 32425521
[TBL] [Abstract][Full Text] [Related]
6. Membrane-Loaded Doxorubicin Liposomes Based on Ion-Pairing Technology with High Drug Loading and pH-Responsive Property.
Xu H; Zhang L; Li L; Liu Y; Chao Y; Liu X; Jin Z; Chen Y; Tang X; He H; Kan Q; Cai C
AAPS PharmSciTech; 2017 Aug; 18(6):2120-2130. PubMed ID: 28028795
[TBL] [Abstract][Full Text] [Related]
7. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma.
Wang X; Zhao Y; Dong S; Lee RJ; Yang D; Zhang H; Teng L
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574945
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
9. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
10. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
Vaidya B; Vyas SP
J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer.
Wang Y; Fu M; Liu J; Yang Y; Yu Y; Li J; Pan W; Fan L; Li G; Li X; Wang X
Int J Nanomedicine; 2019; 14():4071-4090. PubMed ID: 31239668
[No Abstract] [Full Text] [Related]
12. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
13. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
14. Characterization of transferrin-modified procationic-liposome protamine-DNA complexes.
Zhong ZR; Zhang ZR; Liu J; Deng Y; Fu Y; Song QG; He Q
Yakugaku Zasshi; 2007 Mar; 127(3):533-9. PubMed ID: 17329939
[TBL] [Abstract][Full Text] [Related]
15. Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7.
Gandhi R; Khatri N; Baradia D; Vhora I; Misra A
Drug Deliv; 2016 May; 23(4):1152-62. PubMed ID: 25586675
[TBL] [Abstract][Full Text] [Related]
16. Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells.
AlSawaftah NM; Awad NS; Paul V; Kawak PS; Al-Sayah MH; Husseini GA
Sci Rep; 2021 Jun; 11(1):11589. PubMed ID: 34078930
[TBL] [Abstract][Full Text] [Related]
17. Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition.
Chen J; Yao J; Ma Z; Peng P; Lu S; Hu Y; Xu F; Yang Y; Yang X
J Liposome Res; 2017 Mar; 27(1):21-31. PubMed ID: 26911560
[TBL] [Abstract][Full Text] [Related]
18. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
[TBL] [Abstract][Full Text] [Related]
19. The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation
Zhang J; Liang H; Yao H; Qiu Z; Chen X; Hu X; Hu J; Zheng G
Drug Dev Ind Pharm; 2019 Jul; 45(7):1052-1060. PubMed ID: 30939950
[No Abstract] [Full Text] [Related]
20. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
Chang Q; Geng R; Wang S; Qu D; Kong X
Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]